A comprehensive view of regeneron pharmaceuticals inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Regeneron Pharmaceuticals receives Australian patent for CRISPR/Cas screening platform; patent effective from March 17, 2020, till March 17, 2040

REGENERON PHARMACEUTICALS files patent application for CONTINUOUS VIRUS RETENTIVE FILTRATION; filed on Oct. 1, 2021, with inventors Ross BROWNE and Erik SCHNEIDER

Regeneron Pharmaceuticals receives Australian patent for 'GAN-CNN for MHC peptide binding prediction'; effective from Feb. 18, 2019, till Feb. 18, 2039.

Regeneron Pharmaceuticals receives Australian patent for humanized signal-regulatory protein gene in non-human animals; patent effective from Sept 23, 2014, till Sept 23, 2034

REGENERON PHARMACEUTICALS, SANOFI BIOTECHNOLOGY file application for cancer pain treatment method in Australia; inventors include Chieh-I CHEN, Medha R. SASANE, and Denise P. BURY-MAYNARD

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count